Unknown

Dataset Information

0

Antisense Oligonucleotide- and CRISPR-Cas9-Mediated Rescue of mRNA Splicing for a Deep Intronic CLRN1 Mutation.


ABSTRACT: Mutations in CLRN1 cause Usher syndrome (USH) type III (USH3A), a disease characterized by progressive hearing impairment, retinitis pigmentosa, and vestibular dysfunction. Due to the lack of appropriate disease models, no efficient therapy for retinitis pigmentosa in USH patients exists so far. In addition, given the yet undefined functional role and expression of the different CLRN1 splice isoforms in the retina, non-causative therapies such as gene supplementation are unsuitable at this stage. In this study, we focused on the recently identified deep intronic c.254-649T>G CLRN1 splicing mutation and aimed to establish two causative treatment approaches: CRISPR-Cas9-mediated excision of the mutated intronic region and antisense oligonucleotide (AON)-mediated correction of mRNA splicing. The therapeutic potential of these approaches was validated in different cell types transiently or stably expressing CLRN1 minigenes. Both approaches led to substantial correction of the splice defect. Surprisingly, however, no synergistic effect was detected when combining both methods. Finally, the injection of naked AONs into mice expressing the mutant CLRN1 minigene in the retina also led to a significant splice rescue. We propose that both AONs and CRISPR-Cas9 are suitable strategies to initiate advanced preclinical studies for treatment of USH3A patients.

SUBMITTER: Panagiotopoulos AL 

PROVIDER: S-EPMC7452116 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Antisense Oligonucleotide- and CRISPR-Cas9-Mediated Rescue of mRNA Splicing for a Deep Intronic CLRN1 Mutation.

Panagiotopoulos Anna-Lena AL   Karguth Nina N   Pavlou Marina M   Böhm Sybille S   Gasparoni Gilles G   Walter Jörn J   Graf Alexander A   Blum Helmut H   Biel Martin M   Riedmayr Lisa Maria LM   Becirovic Elvir E  

Molecular therapy. Nucleic acids 20200731


Mutations in CLRN1 cause Usher syndrome (USH) type III (USH3A), a disease characterized by progressive hearing impairment, retinitis pigmentosa, and vestibular dysfunction. Due to the lack of appropriate disease models, no efficient therapy for retinitis pigmentosa in USH patients exists so far. In addition, given the yet undefined functional role and expression of the different CLRN1 splice isoforms in the retina, non-causative therapies such as gene supplementation are unsuitable at this stage  ...[more]

Similar Datasets

| S-EPMC9595628 | biostudies-literature
| S-EPMC6628380 | biostudies-literature
| S-EPMC5581164 | biostudies-literature
| S-EPMC5155325 | biostudies-literature
| S-EPMC10661860 | biostudies-literature
| S-EPMC8124656 | biostudies-literature
| S-EPMC3722957 | biostudies-literature
| S-EPMC6086559 | biostudies-literature
| S-EPMC7350697 | biostudies-literature
| S-EPMC1784105 | biostudies-literature